S

South Jersey Infectious Disease | Somers Point, NJ

Research site
(Unclaimed)
Location
730 Shore Road, Somers Point, New Jersey, United States of America
Site insights

Top conditions

HIV Infections (18 trials)

Infections (8 trials)

Communicable Diseases (8 trials)

Acquired Immunodeficiency Syndrome (6 trials)

Immunologic Deficiency Syndromes (5 trials)

Top treatments

Emtricitabine
Tenofovir Disoproxil Fumarate
Tenofovir Alafenamide
Atazanavir
Efavirenz
Ritonavir
TAF
Elvitegravir
Rilpivirine
TDF

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

7 of 46
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Clinical Trial of STP0404 in Treatment-Naïve Adults With HIV-1 Infection

The purpose of this study is to evaluate the antiviral effect, safety, tolerability, and pharmacokinetics of STP0404 in treatment naïve adult partici...

Enrolling
HIV-1-infection
Drug: Low-dose STP0404 (Pirmitegravir)
Drug: Placebo
Locations recently updated

Human immuno-deficiency virus (HIV) is the virus that causes Acquired Immuno-Deficiency Syndrome (AIDS). HIV disease is considered to be a chronic di...

Enrolling
Human Immuno-deficiency Virus (HIV) Disease
Drug: Budigalimab
Drug: Placebo for Budigalimab

The purpose of this clinical study is to learn about the safety, extent of the side effects (reaction to vaccine), and immune response (your immune s...

Enrolling
Shingles
Human
Biological: Selected Vaccine Candidate group (Dose level, Schedule)
Biological: Shingrix - SSB

This is a Phase 3, multicenter, randomized, double-blind, safety and efficacy study of contezolid acefosamil (IV)/contezolid (PO) compared with linez...

Enrolling
Diabetic Foot Infection
Drug: Linezolid (IV and PO)
Drug: contezolid acefosamil (IV)/contezolid (PO)

The goal of this clinical study is to test how well the study drug, lenacapavir (LEN), works in preventing the risk of HIV.

Active, not recruiting
Pre-Exposure Prophylaxis of HIV Infection
Drug: Oral Lenacapavir (LEN)
Drug: F/TDF

The goal of this clinical study is to learn more about the effects of switching to the study drugs, bictegravir (BIC)/lenacapavir (LEN), fixed-dose c...

Enrolling
HIV-1-infection
Drug: B/F/TAF
Drug: Placebo to match B/F/TAF

Efficacy Study: This randomized, double-blinded, placebo-controlled Phase 3 study is designed to assess the safety, immunogenicity, and efficacy of a...

Active, not recruiting
Lower Respiratory Tract Illness
Biological: Placebo
Biological: RSVpreF

Trial sponsors

Gilead Sciences logo

Gilead Sciences (17 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems